Literature DB >> 2115571

Preferential rearrangement of V kappa 4 gene segments in pre-B cell lines.

S L Kalled1, P H Brodeur.   

Abstract

Examination of the in vitro V kappa gene rearrangements of murine adult bone marrow-derived pre-B cell lines reveals that 21 of 25 (84%) cell lines have rearranged a member of the V kappa 4 family. In contrast, analysis of two V kappa cDNA libraries prepared from LPS-stimulated adult spleen cells indicates that only 17% of the Ig kappa cDNAs contain sequences belonging to the V kappa 4 gene family. Half of the pre-B cell lines examined also share an 8-kbp BamHI reciprocal product (rp). However, these rp do not involve the same V kappa gene, indicating that conserved BamHI sites exist 3' of some V kappa genes. This rp is also readily detected in DNA from normal adult spleen cells, suggesting that the in vitro rearrangements examined in this study are representative of kappa rearrangements that occur in vivo. We suggest that, unlike the diverse V kappa repertoire expressed by mature B cells, the germline V kappa segments involved in initial rearrangements of the Ig kappa locus are highly restricted, and that an initial V kappa 4 rearrangement is probably followed by other, more random recombination events.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2115571      PMCID: PMC2188324          DOI: 10.1084/jem.172.2.559

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  32 in total

1.  Double recombination of a single immunoglobulin kappa-chain allele: implications for the mechanism of rearrangement.

Authors:  R M Feddersen; B G Van Ness
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

2.  Multiple related immunoglobulin variable-region genes identified by cloning and sequence analysis.

Authors:  J G Seidman; A Leder; M H Edgell; F Polsky; S M Tilghman; D C Tiemeier; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

3.  Developmentally controlled expression of immunoglobulin VH genes.

Authors:  R M Perlmutter; J F Kearney; S P Chang; L E Hood
Journal:  Science       Date:  1985-03-29       Impact factor: 47.728

4.  Preferential utilization of the most JH-proximal VH gene segments in pre-B-cell lines.

Authors:  G D Yancopoulos; S V Desiderio; M Paskind; J F Kearney; D Baltimore; F W Alt
Journal:  Nature       Date:  1984 Oct 25-31       Impact factor: 49.962

5.  Cloning of V region fragments from mouse liver DNA and localization of repetitive DNA sequences in the vicinity of immunoglobulin gene segments.

Authors:  M Steinmetz; J Höchtl; H Schnell; W Gebhard; H G Zachau
Journal:  Nucleic Acids Res       Date:  1980-04-25       Impact factor: 16.971

6.  Immunoglobulin gene 'remnant' DNA--implications for antibody gene recombination.

Authors:  E Selsing; J Voss; U Storb
Journal:  Nucleic Acids Res       Date:  1984-05-25       Impact factor: 16.971

7.  DNA between variable and joining gene segments of immunoglobulin kappa light chain is frequently retained in cells that rearrange the kappa locus.

Authors:  B G Van Ness; C Coleclough; R P Perry; M Weigert
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

8.  Immunoglobulin genes of different subgroups are interdigitated within the VK locus.

Authors:  M Pech; H G Zachau
Journal:  Nucleic Acids Res       Date:  1984-12-21       Impact factor: 16.971

9.  Classification of mouse VK groups based on the partial amino acid sequence to the first invariant tryptophan: impact of 14 new sequences from IgG myeloma proteins.

Authors:  M Potter; J B Newell; S Rudikoff; E Haber
Journal:  Mol Immunol       Date:  1982-12       Impact factor: 4.407

10.  Light chain germ-line genes and the immune response to 2-phenyloxazolone.

Authors:  J Even; G M Griffiths; C Berek; C Milstein
Journal:  EMBO J       Date:  1985-12-16       Impact factor: 11.598

View more
  10 in total

1.  Skewed primary Igκ repertoire and V-J joining in C57BL/6 mice: implications for recombination accessibility and receptor editing.

Authors:  Miyo Aoki-Ota; Ali Torkamani; Takayuki Ota; Nicholas Schork; David Nemazee
Journal:  J Immunol       Date:  2012-01-27       Impact factor: 5.422

2.  RAG-1 and RAG-2 are not sufficient to direct all phases of immunoglobulin gene rearrangement in pre-B-cell lines.

Authors:  L C Wang; N Rosenberg
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

3.  In vivo VL-targeted microbial superantigen induced global shifts in the B cell repertoire.

Authors:  Caroline Grönwall; Sergei L Kosakovsky Pond; Jason A Young; Gregg J Silverman
Journal:  J Immunol       Date:  2012-06-13       Impact factor: 5.422

4.  Assembly and analysis of the mouse immunoglobulin kappa gene sequence.

Authors:  Katherine M Brekke; William T Garrard
Journal:  Immunogenetics       Date:  2004-09-18       Impact factor: 2.846

5.  Evolutionary relationship between human and mouse immunoglobulin kappa light chain variable region genes.

Authors:  G Kroemer; A Helmberg; A Bernot; C Auffray; R Kofler
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

6.  Class switch recombination and somatic hypermutation in early mouse B cells are mediated by B cell and Toll-like receptors.

Authors:  Jin-Hwan Han; Shizuo Akira; Kathryn Calame; Bruce Beutler; Erik Selsing; Thereza Imanishi-Kari
Journal:  Immunity       Date:  2007-07-19       Impact factor: 31.745

7.  Restricted kappa chain expression in early ontogeny: biased utilization of V kappa exons and preferential V kappa-J kappa recombinations.

Authors:  C A Medina; J M Teale
Journal:  J Exp Med       Date:  1993-05-01       Impact factor: 14.307

8.  Selection at multiple checkpoints focuses V(H)12 B cell differentiation toward a single B-1 cell specificity.

Authors:  C Tatu; J Ye; L W Arnold; S H Clarke
Journal:  J Exp Med       Date:  1999-10-04       Impact factor: 14.307

9.  Breakdown of B cell tolerance in a mouse model of systemic lupus erythematosus.

Authors:  J H Roark; C L Kuntz; K A Nguyen; A J Caton; J Erikson
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

10.  In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. I. The architecture and dynamics of responding cell populations.

Authors:  J Jacob; R Kassir; G Kelsoe
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.